Organisation: BioNTech

A COMPREHENSIVE SERIES OF ARTICLES ON THIS TOPIC

<p>Third-quarter sales of the Covid-19 vaccine came in at $4.4bn, blowing past estimates of $2.6bn.</p>

companies

Pfizer predicts Covid-19 vaccines will remain 'multi-billion-dollar revenue generators'

Company plans to quadruple the price of the vaccine in the US once the US government stops buying doses and shifts to a private market

<p>Moderna on its own, and the partnership of Pfizer and BioNTech were two of the first groups to develop a vaccine for the novel coronavirus.</p>

companies

Moderna sues Pfizer/BioNTech over Covid vaccine

Moderna is suing Pfizer and its German partner BioNTech for patent infringement in the development of the first Covid-19 vaccine approved in the US, alleging they copied technology that Moderna developed years before the pandemic.

<p>The German biotech firm is forecasting a full-year decline in vaccine sales.</p>

companies

Pfizer-partner BioNTech forecasts decline in vaccine sales for full year

Moderna was more bullish last week, forecasting higher vaccine sales for the second half of the year than in the first, as it expects demand for booster shots in the autumn

news

Seven children mistakenly given adult vaccine dosage

companies

Shingles is latest target of Covid vaccine makers Pfizer and BioNTech

companies

Pfizer expects €25bn in Covid vaccine sales in 2022

SAFRICA-POLITICS-HEALTH-VIRUS-VACCINE-DEMONSTRATION

Amnesty slams pharmas over 'unprecedented human rights crisis' of vaccine inequality

Amnesty International has criticised AstraZeneca, BioNTech, Johnson and Johnson, Moderna, Novavax, and Pfizer for refusing to participate in initiatives aimed at boosting global vaccine supply

Wed, 22 Sep, 2021

Vaccine makers Pfizer and Moderna may tap €5bn from annual booster shots

Drugmakers Pfizer, BioNTech, and Moderna are expected to reap billions of euros from Covid-19 booster shots in a market that could rival the $6bn (€5bn) in annual sales for flu vaccines for years to come, analysts and healthcare investors say.

Fri, 13 Aug, 2021

Vaccine producer BioNTech set to deliver huge boost to German economy

Development and domestic production of groundbreaking Covid-19 vaccine by German start-up BioNTech could boost economic growth in Europe's largest economy by up to 0.5 percentage points this year, says economist

Tue, 10 Aug, 2021

AstraZeneca shares fall as Britain issues latest vaccine blood clot data

Shares of its main European rival, BioNTech, climbed sharply in Frankfurt trade

Fri, 02 Apr, 2021

Ireland's Covid cases are rising, but we are still in a good position compared to our neighbours

There is hope now for an end to the Covid-19 pandemic but many months to go before normality returns.

Wed, 16 Dec, 2020

Covid-19: Taoiseach warns of 'huge' project to roll out vaccine

Taoiseach Micheál Martin told the Dáil that he would not be nominating one person to oversee the project but will, instead, rely on the expertise and experience of health officials.

Wed, 02 Dec, 2020

Covid-19: The immigrant heroes behind the BioNTech vaccine

Ugur Sahin and Ozlem Tureci are the co-founders of BioNTech SE, the German company that — with its American partner Pfizer — appears closest to rolling out a working vaccine against Covid-19

Sun, 15 Nov, 2020

Covid-19 vaccine news hints at windfall for Irish Pfizer shareholders

Pfizer has around 4,000 employees in Ireland currently, including around 800 in Ringaskiddy and Little Island in Cork.

Mon, 09 Nov, 2020

Pfizer Inc. Research And Development Center Ahead Of Earnings Figures

Pfizer and BioNTech may know before rivals about Covid vaccine shot

Companies plan first look after 32 coronavirus infections in massive 44-000-person trial

Tue, 22 Sep, 2020

John Whelan: Frantic drive underway to develop a vaccine

The drive to find a vaccine to combat the coronavirus is well underway. Several large pharmaceutical and smaller biotech companies are working on making new antibodies, drugs and vaccines to combat the coronavirus disease but lack of funds may yet get in the way, writes John Whelan.

Sun, 22 Mar, 2020